[China Jo-Jo Drugstores, Inc. Receives Delisting Notice from NASDAQ HANGZHOU, China--(BUSINESS WIRE)--China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) (the “Company”), a retail and wholesale distributor of pharmaceutical and other healthcare products in China, today announced that on August 31, 2012, it was notified by The NASDAQ Stock Market LLC (“NASDAQ”), notifying it of its failure to maintain a minimum closing bid price]
[FORM 10-Q/A þ For the quarterly period ended June 30, 2012 or o For the transition period from ____________________________________ to ________________________________________ 001-34711 CHINA JO-JO DRUGSTORES, INC. Nevada 98-0557852 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Room 507-513, 5th Floor A Building, Meidu Plaza Gongshu District Hangzhou, Zhejiang Province People’s Republic of China (Zip Code) +86]
[FORM 10-Q/A þ For the quarterly period ended June 30, 2012 or o For the transition period from ____________________________________ to ________________________________________ 001-34711 CHINA JO-JO DRUGSTORES, INC. Nevada 98-0557852 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Room 507-513, 5th Floor A Building, Meidu Plaza Gongshu District Hangzhou, Zhejiang Province People’s Republic of China (Zip Code) +86]
[99 China Jo-Jo Drugstores, Inc. Reports Fiscal First Quarter 2013 Revenue and Schedules First Quarter FY 2013 Conference Call Business Wire HANGZHOU, China -- August 14, 2012 China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD), (the “Company”), a retail and wholesale distributor of pharmaceutical and other healthcare products in Zhejiang and Shanghai, today reported earnings results for the first quarter of fiscal 2013]
[99 China Jo-Jo Drugstores, Inc. Reports Fiscal First Quarter 2013 Revenue and Schedules First Quarter FY 2013 Conference Call Business Wire HANGZHOU, China -- August 14, 2012 China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD), (the “Company”), a retail and wholesale distributor of pharmaceutical and other healthcare products in Zhejiang and Shanghai, today reported earnings results for the first quarter of fiscal 2013]
[FORM 10-Q þ For the quarterly period ended June 30, 2012 or o For the transition period from ____________________________________ to ________________________________________ 001-34711 CHINA JO-JO DRUGSTORES, INC. Nevada 98-0557852 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Room 507-513, 5th Floor A Building, Meidu Plaza Gongshu District Hangzhou, Zhejiang Province People’s Republic of China (Zip Code) +86] [CERTIFICATION I, Lei Liu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Ming Zhao, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Lei Liu Lei Liu Chief Executive Officer EX-32.1 4 f10q0612ex32i_chinajojo.htm SECTION 906 CERTIFICATION BY THE CORPORATION?S CHIEF EXECUTIVE OFFICER *] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ming Zhao Ming Zhao Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 f10q0612ex32ii_chinajojo.htm SECTION 906 CERTIFICATION BY THE CORPORATION?S CHIEF FINANCIAL OFFICER *]
[FORM 10-Q þ For the quarterly period ended June 30, 2012 or o For the transition period from ____________________________________ to ________________________________________ 001-34711 CHINA JO-JO DRUGSTORES, INC. Nevada 98-0557852 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Room 507-513, 5th Floor A Building, Meidu Plaza Gongshu District Hangzhou, Zhejiang Province People’s Republic of China (Zip Code) +86] [CERTIFICATION I, Lei Liu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Ming Zhao, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Lei Liu Lei Liu Chief Executive Officer EX-32.1 4 f10q0612ex32i_chinajojo.htm SECTION 906 CERTIFICATION BY THE CORPORATION?S CHIEF EXECUTIVE OFFICER *] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ming Zhao Ming Zhao Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 f10q0612ex32ii_chinajojo.htm SECTION 906 CERTIFICATION BY THE CORPORATION?S CHIEF FINANCIAL OFFICER *]
[FORM 10-K þ For the fiscal year ended March 31, 2012 or o For the transition period from ____________________________________ to ________________________________________ 001-34711 CHINA JO-JO DRUGSTORES, INC . (Exact name of issuer as specified in its charter) Nevada 98-0557852 (State or other jurisdiction of incorporation or organization) (I.R.S. employer identification number) Room 507-513, 5th Floor A Building, Meidu Plaza Gongshu District] [List of Subsidiaries 1. Renovation Investment (Hong Kong) Co., Ltd. (“Renovation”) is a Hong Kong company and is wholly-owned by the Company. 2. Hangzhou Jiutong Medical Technology Co., Ltd. is a Chinese company and is wholly-owned by Renovation. 3. Zhejiang Shouantang Pharmaceutical Technology Co., Ltd. (“Shouantang Technology”) is a Chinese company and is wholly-owned by Renovation. 4. Zhejiang Jiuxin Investment] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (File No. 333-171849) of China Jo-Jo Drugstores, Inc. and subsidiaries of our reports dated July 2, 2012 relating to the consolidated financial statements, which appear in this Form 10-K. New York, New York July 2, 2012 EX-23.1 3] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Lei Liu, certify that: 1. I have reviewed this annual report on Form 10-K of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Ming Zhao, certify that: 1. I have reviewed this annual report on Form 10-K of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Lei Liu Chief Executive Officer July 2, 2012 EX-32.1 6 f10kex32i_chinajojo.htm CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Ming Zhao Chief Financial Officer July 2, 2012 EX-32.2 7 f10kex32ii_chinajojo.htm CERTIFICATION]
[China Jo-Jo Drugstores, Inc. Reports Fiscal Year 2012 Earnings Results and schedules conference call for July 3, 2012 Fiscal Year 2012 Highlights: --Revenues reached record $94.4 million --Gross profit rose 30% to $27.6 million, gross margin 29% --Sales from the cultivation of Traditional Chinese Medicines were $4.2 million, from online drug sales was $1.1 million --Net income $8.1 million --Diluted]
[China Jo-Jo Drugstores, Inc. Reports Fiscal Year 2012 Earnings Results and schedules conference call for July 3, 2012 Fiscal Year 2012 Highlights: --Revenues reached record $94.4 million --Gross profit rose 30% to $27.6 million, gross margin 29% --Sales from the cultivation of Traditional Chinese Medicines were $4.2 million, from online drug sales was $1.1 million --Net income $8.1 million --Diluted]
